OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
6
Results
Show all
Save search
Copy query
Show results for
Unknown
(5)
Proteomics
(1)
Organisms
Eospalax fontanierii baileyi
(1)
Repository
iProX
(1)
Publication Date
2026
(1)
Release Date
2024
(2)
2020
(2)
2022
(1)
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
Qingfei mixture modulates the immune responses in lung cancer through modulating mTOR signaling and gut microbiota-derived short-chain fatty acids.
Not available
S-EPMC11041045
|
biostudies-literature
Cite
Anti-inflammatory activities of Qingfei oral liquid and its influence on respiratory microbiota in mice with ovalbumin-induced asthma.
Not available
S-EPMC9445488
|
biostudies-literature
Cite
Association between early treatment with Qingfei Paidu decoction and favorable clinical outcomes in patients with COVID-19: A retrospective multicenter cohort study.
Not available
S-EPMC7833425
|
biostudies-literature
Cite
Network pharmacology, molecular docking, and untargeted metabolomics reveal molecular mechanisms of multi-targets effects of Qingfei Tongluo Plaster improving respiratory syncytial virus pneumonia.
Not available
S-EPMC11589485
|
biostudies-literature
Cite
Chemoprophylaxis, diagnosis, treatments, and discharge management of COVID-19: An evidence-based clinical practice guideline (updated version).
Not available
S-EPMC7472403
|
biostudies-literature
Cite
Cleavage sites of SQLE and SREBP2 proteins in Eospalax baileyi
Experimentally validated cleavage sites of SQLE and SREBP2 proteins in plateau zokor (Eospalax baileyi)
ORGANISM(S):
Eospalax Fontanierii Baileyi
2026-04-28
|
PXD077704
|
Cite
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets